دورية أكاديمية

Alemtuzumab:egy új terápia előnyei és kihívásai sclerosis multiplexben ; ALEMTUZUMAB:Benefits and challenges of new therapy in multiple sclerosis

التفاصيل البيبلوغرافية
العنوان: Alemtuzumab:egy új terápia előnyei és kihívásai sclerosis multiplexben ; ALEMTUZUMAB:Benefits and challenges of new therapy in multiple sclerosis
المؤلفون: Illés, Zsolt, Sejbaek, Tobias, Csépány, Tünde
المصدر: Illés , Z , Sejbaek , T & Csépány , T 2015 , ' Alemtuzumab : egy új terápia előnyei és kihívásai sclerosis multiplexben ' , Ideggyogyaszati Szemle , bind 68 , nr. 5-6 , s. 155-164 . https://doi.org/10.18071/isz.68.0155Test
سنة النشر: 2015
المجموعة: University of Southern Denmark: Research Output / Syddansk Universitet
مصطلحات موضوعية: Adjuvants, Immunologic, Adult, Antibodies, Monoclonal, Humanized, Brain, Clinical Trials as Topic, Disease Progression, Drug Administration Schedule, Europe, Female, Humans, Interferon beta-1a, Interferon-beta, Magnetic Resonance Imaging, Multiple Sclerosis, Relapsing-Remitting, Myelitis, Transverse, Spinal Cord, Treatment Outcome, Relapse, Secunder autoimmunity, UP, EDSS, Alemtuzumab, Interferon-j31 a
الوصف: The widening spectrum of MS treatment is partially due to increasing knowledge about the pathogenesis of MS. The humanized monoclonal antibody against CD52, alemtuzumab has been approved in Europe for the treatment of MS, which results in long-term depletion of B and T cells due to complement- and antibody-mediated cytotoxicity. Based on phase 2 and 3 clinical trials, alemtuzumob decreases the risk of sustained neurological deficit and progression compared to high-dose subcutaneous interferon-β1a in patients with active relapsing-remitting MS, either treatment-naïve or with breakthrough disease. We review advantages and benefits of the treatment, discuss safety concerns, and present a case to describe practical issues.
نوع الوثيقة: article in journal/newspaper
اللغة: Hungarian
العلاقة: https://portal.findresearcher.sdu.dk/da/publications/37bffbae-147b-4575-aa49-22694ad4739aTest
DOI: 10.18071/isz.68.0155
الإتاحة: https://doi.org/10.18071/isz.68.0155Test
https://portal.findresearcher.sdu.dk/da/publications/37bffbae-147b-4575-aa49-22694ad4739aTest
حقوق: info:eu-repo/semantics/openAccess
رقم الانضمام: edsbas.F9F70F1B
قاعدة البيانات: BASE